The Optimult study concept - Selective neoadjuvant chemoradiation therapy based on preoperative MRI?;Das optimult-studienkonzept - Grundlage für selektiven einsatz neoadjuvanter radiochemotherapie auf MRT-basis?

Zentralblatt fur Chirurgie - Zeitschrift fur Allgemeine, Viszeral- und Gefasschirurgie

Volumn 135, Issue 4, 2010, Pages 302-306

  Kreis, M E ^a   Junginger, T ^b   Rodel C ^c   Heinemanne, V ^a   Konstantin, N ^d   Mansmann, U ^d   Jauch, K W ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

^c GOETHE UNIVERSITY   (Germany)

^d UNIVERSITY OF MUNICH   (Germany)

Author keywords

local recurrence of tumour growth; quality of life; rectal carcinoma cancer

Indexed keywords

ADJUVANT THERAPY; ARTICLE; CANCER INVASION; CANCER STAGING; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE FREE SURVIVAL; GERMANY; HUMAN; MULTICENTER STUDY; MULTIMODALITY CANCER THERAPY; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; PATIENT SELECTION; POSTOPERATIVE COMPLICATION; PRACTICE GUIDELINE; PROGNOSIS; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; RECTUM; RECTUM TUMOR; REOPERATION; TREATMENT OUTCOME; TUMOR RECURRENCE;

COMBINED MODALITY THERAPY; DISEASE-FREE SURVIVAL; GERMANY; GUIDELINE ADHERENCE; HUMANS; MAGNETIC RESONANCE IMAGING; NEOADJUVANT THERAPY; NEOPLASM INVASIVENESS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PATIENT SELECTION; POSTOPERATIVE COMPLICATIONS; PROGNOSIS; QUALITY OF LIFE; RECTAL NEOPLASMS; RECTUM; REOPERATION; TREATMENT OUTCOME;

EID: 77956316530     PISSN: 0044409X     EISSN: 14389592     Source Type: Journal    
DOI: 10.1055/s-0030-1262523     Document Type: Article

References (40)

1. Enker W E. Designing the optimal surgery for rectal carcinoma. Cancer 1996 78 1847-1850
2. Junginger T, Hermanek P, Oberholzer K et al. Rektumkarzinom: Behandeln wir zu häufig neoadjuvant? Vorschläge zu einer selektiveren, MRT-basierten Indikation. Zentralbl Chir 2006 131 275-284
3. Bokey E L., Öjerskog B, Chapuis P H. et al. Local recurrence after curative excision of the rectum for cancer without adjuvant therapy: role of total anatomic dissection. Br J Surg 1999 86 1164-1170
4. Heald R J., Husband E M., Ryall R D. The mesorectum in rectal cancer surgery the clue to pelvic recurrence? Br J Surg 1982 69 613-616
5. Sebag-Montefiore D, Stephens R J., Steele R et al. Preoperative radiotherapy versus slelective posopterative chemoradiotherapy in patients with rectal cancer (MRC CR07 and NCIC-CTG C016): a multicentre, randomized trial. Lancet 2009 373 811-820
6. Kapiteijn E, Marijnen C A., Nagtegaal I D. et al. Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer. N Engl J Med 2001 345 638-646
7. Sauer R, Becker H, Hohenberger W, et al., German Rectal Cancer Study Group. Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med 2004 351 1731-1740
8. Wong R K., Berry S, Spithoff K, et al., Gastrointestinal Cancer Disease Site Group (2010). Preoperative or postoperative therapy for stageII or III rectal cancer: an update practice guideline. Clin Oncol (R Coll Radiol) 2010 22 265-271
9. Nagtegaal I D., Marijnen C AM, Kranenberg E K. et al. Circumferential margin involvement is still an important predictor of local recurrence in rectal carcinoma. Am J Surg Pathol 2002 26 350-357
10. Rau B, Hohenberger P, Gellermann J et al. T4 rectal carcinoma. Surgical and multimodal therapy. Chirurg 2002 73 147-153
11. Bujko K, Nowacki M P., Nasierowska-Guttmejer A et al. Sphincter preservation following preoperative radiotherapy for rectal cancer: report of a randomised trial comparing short-term radiotherapy vs. conventionally fractionated radiochemotherapy. Radiother Oncol 2004 72 15-24
12. Buijko K, Kepka L, Michalski W et al. Does rectal cancer shrinkage induced by preoperative radio(chemo)therapy increase the likelihood of anterior resection? A systematic review of randomised trials. Radiother Oncol 2006 80 4-12
13. Maurer C A., ZGraggen K, Renzulli P et al. Total mesorectal excision preserves male genital function compared with conventional rectal cancer surgery. Br J Surg 2001 88 1501-1505
14. Peeters K C., van de Velde C J., Leer J W. et al. Late side effects of short-course preoperative radiotherapy combined with total mesorectal excision for rectal cancer: increased bowel dysfunction in irradiated patients a Dutch colorectal cancer group study. J Clin Oncol 2005 23 6199-6206
15. Pollack J, Holm T, Cedermark B et al. Long-term effect of preoperative radiation therapy on anorectal function. Dis Colon Rectum 2006 49 345-352
16. Gervaz P, Rotholtz N, Pisano M et al. Quantitative short-term study of anal sphincter function after chemoradiation for rectal cancer. Arch Surg 2001 136 192-196
17. Ammann K, Kirchmayr W, Klaus A et al. Impact of neoadjuvant chemoradiation on anal sphincter function in patients with carcinoma of the midrectum and low rectum. Arch Surg 2003 138 257-261
18. Jang N Y., Han T J., Kang S B. et al. The short-term effect of neoadjuvant chemoradiation on anorectal function in low and midrectal cancer: analysis using preoperative manometric data. Dis Colon Rectum 2010 53 445-449
19. Pietrzak L, Bujko K, Nowacki M P. et al. Quality of life, anorectal and sexual functions after preoperative radiotherapy for rectal cancer: report of a randomised trial. Radiother Oncol 2007 84 217-225
20. Pietsch A P., Fietkau R, Klautke G et al. Effect of neoadjuvant chemoradiation on postoperative fecal continence and anal sphincter function in rectal cancer patients. Int J Colorectal Dis 2007 22 1311-1317
21. Birbeck K F., Macklin C P., Tiffin N J. et al. Rates of circumferential resection margin involvement vary between surgeons and predict outcomes in rectal cancer surgery. Ann Surg 2002 35 449-457
22. Bittner R, Burghardt J, Gross E et al., (Arbeitsgruppe Workflow RektumkarzinomII). Qualitätsindikatoren bei Diagnostik und Therapie des Rektumkarzinoms. Zentralbl Chir 2007 132 85-94
23. Glynne-Jones R, Mawdsley S, Pearce T et al. Alternative clinical end points in rectal cancer are we getting closer? Ann Oncol 2006 17 1239-1242
24. Mawdsley S, Glynne-Jones R, Grainger J et al. Can histopathologic assessment of circumferential margin after preoperative pelvic clearance therapy for T3T4 rectal cancer predict for 3-year disease-free survival? Int J Radiat Oncol Biol Phys 2005 63 745-750
25. Strassburg J, Junginger T, Trinh T et al. Magnetic resonance imaging (MRI)-based indication for neoadjuvant treatment of rectal carcinoma and the surrogate endpoint CRM status. Int J Colorect Dis 2008 23 1099-1107
26. Eriksen M T., Wibe A, Haffner J, et al., Norwegian Rectal Cancer Group. Prognostic groups in 1676patients with T3 rectal cancer treated without preoperative radiotherapy. Dis Colon Rectum 2007 50 156-167
27. Nagtegaal I D., Marijnen C AM, Kranenberg E K. et al. Circumferential margin involvement is still an important predictor of local recurrence in rectal carcinoma. Am J Surg Pathol 2002 26 350-357
28. Nagtegaal I D., Quirke P. What is the role of the circumferential margin in the modern treatment of rectal cancer. J Clin Oncol 2008 26 303-312
29. Nagtegaal I D., Gosens M J., Marijnen C A. et al. Combinations of tumor and treatment parameters are more discriminative for prognosis than the present TNM system in rectal cancer. J Clin Oncol 2007 25 1647-1650
30. Beets-Tan R GH, Beets G L. Rectal cancer: Review with emphasis on MR imaging. Radiol 2004 232 335-346
31. Brown G, Richards C J., Newcombe R G. et al. Rectal carcinoma: thin-section MR imaging for staging in 28patients. Radiology 1999 211 215-222
32. MERCURY Study Group. Diagnostic accuracy of preoperative magnetic resonance imaging in predictiong curative resection of rectal cancer: prospective observational study. Br Med J 2006 333 779-784
33. Hermanek P, Junginger T, Merkel S et al. High-resolution magnetic resonance imaging (MRI) in patients with rectal carcinoma: Effectiveness in selection for neoadjuvant treatment. Recent Res Devel Cancer 2006 8 39-56
34. Crawshaw A, Hennigan R, Smedley F H. et al. Perioperative radiotherapy for rectal cancer: the case for a selective pre-operative approach the third way. Colorectal Dis 2003 5 367-372
35. Burton S, Brown G, Daniels I R., et al. on behalf of the Royal Marsden Hospital, Colorectal Cancer Network. MRI directed multidisciplinary team preoperative treatment strategy: the way to eliminate positive circumferential margins? Br J Cancer 2006 94 351-357
36. Chau I, Brown G, Cunningham D et al. Neoadjuvant capecitabine and oxaliplatin followed by synchronous chemoradiation and total mesorectal excision in magnetic resonance imaging-defined poor-risk rectal cancer. J Clin Oncol 2006 24 668-674
37. Engelen S, Lahaye M J., Beets-Tan R G. et al. Tailored treatment of primary rectal cancer based on MRI: does it reduce the number of incomplete resections? Abstract. Ann Oncol 2008 19 Suppl1 1-17
38. Brown G, Daniels I R. Preoperative staging of rectal cancer: the MERCURY research project. Recent Results Cancer Research 2005 165 58-74
39. Schmiegel W, Pox C, Reinacher-Schick A et al. S3-Leitlinie Kolorektales Karzinom. Z Gastroenterol 2008 46 1-73
40. Hermanek P, Hohenberger W, Fietkau R et al. Individualized MRI-based neoadjuvant chemoradiation for middle and lower rectal carcinoma. Colorectal Dis 2009 [Epub ahead of print]